Jeff Geschwind, MD: Cancer Drug Developer Founder of Cage Pharma, Jeff Geschwind, MD, targets cancer metabolism (glycolysis) to design novel drugs. His startup bridges lab research and clinical applications for aggressive tumors. https://www.linkedin.com/in/jeff-geschwind-037200174